The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share
Mengyuan Diao(Hangzhou First People's Hospital), Wei Hu(Zhejiang Chinese Medical University), Dechang Chen(Shanghai Jiao Tong University), Sheng Zhang(Shanghai East Hospital)
Cited by 14
Related Papers
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study
|Annals of Intensive Care|2020|146
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
|The Lancet Regional Health - Western Pacific|2023|112
Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig
|bioRxiv (Cold Spring Harbor Laboratory)|2020|94
Expert consensus on the use of human serum albumin in critically ill patients
|Chinese Medical Journal|2021|70